<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <introducedDate>2015-02-05</introducedDate>
    <committeeReports />
    <laws />
    <createDate>2015-02-06T04:59:51Z</createDate>
    <actions>
      <actionByCounts>
        <houseOfRepresentatives>4</houseOfRepresentatives>
      </actionByCounts>
      <item>
        <actionDate>2015-02-06</actionDate>
        <committee>
          <name>Health Subcommittee</name>
          <systemCode>hsif14</systemCode>
        </committee>
        <links />
        <sourceSystem>
          <name>House committee actions</name>
          <code>1</code>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2015-02-05</actionDate>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <committee>
          <name>Energy and Commerce Committee</name>
          <systemCode>hsif00</systemCode>
        </committee>
        <text>Referred to the House Committee on Energy and Commerce.</text>
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
        <links />
      </item>
      <item>
        <actionDate>2015-02-05</actionDate>
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <committee />
        <text>Introduced in House</text>
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
        <links />
      </item>
      <item>
        <actionDate>2015-02-05</actionDate>
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <committee />
        <text>Introduced in House</text>
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
        <links />
      </item>
      <actionTypeCounts>
        <billReferrals>1</billReferrals>
        <introducedInTheHouse>1</introducedInTheHouse>
        <placeholderTextForH>1</placeholderTextForH>
        <introducedInHouse>1</introducedInHouse>
      </actionTypeCounts>
    </actions>
    <recordedVotes />
    <relatedBills />
    <cosponsors>
      <item>
        <identifiers>
          <lisID>1634</lisID>
          <gpoId>7820</gpoId>
          <bioguideId>H001034</bioguideId>
        </identifiers>
        <state>CA</state>
        <sponsorshipDate>2015-04-23</sponsorshipDate>
        <district>17</district>
        <middleName>M.</middleName>
        <party>D</party>
        <sponsorshipWithdrawnDate />
        <bioguideId>H001034</bioguideId>
        <lastName>HONDA</lastName>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <fullName>Rep. Honda, Michael M. [D-CA-17]</fullName>
        <firstName>MICHAEL</firstName>
      </item>
      <item>
        <identifiers>
          <gpoId />
          <bioguideId>P000608</bioguideId>
          <lisID>2113</lisID>
        </identifiers>
        <state>CA</state>
        <sponsorshipDate>2015-04-23</sponsorshipDate>
        <district>52</district>
        <middleName>H.</middleName>
        <party>D</party>
        <sponsorshipWithdrawnDate />
        <bioguideId>P000608</bioguideId>
        <lastName>Peters</lastName>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <fullName>Rep. Peters, Scott H. [D-CA-52]</fullName>
        <firstName>Scott</firstName>
      </item>
    </cosponsors>
    <billNumber>95</billNumber>
    <amendments />
    <subjects>
      <billSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
        <legislativeSubjects>
          <item>
            <name>Advanced technology and technological innovations</name>
          </item>
          <item>
            <name>Biological and life sciences</name>
          </item>
          <item>
            <name>Department of Health and Human Services</name>
          </item>
          <item>
            <name>Drug safety, medical device, and laboratory regulation</name>
          </item>
          <item>
            <name>Executive agency funding and structure</name>
          </item>
          <item>
            <name>Food and Drug Administration (FDA)</name>
          </item>
          <item>
            <name>Health programs administration and funding</name>
          </item>
          <item>
            <name>Health technology, devices, supplies</name>
          </item>
          <item>
            <name>Medical research</name>
          </item>
          <item>
            <name>Research administration and funding</name>
          </item>
          <item>
            <name>Research and development</name>
          </item>
        </legislativeSubjects>
      </billSubjects>
    </subjects>
    <sponsors>
      <item>
        <party>D</party>
        <state>CA</state>
        <middleName />
        <bioguideId>V000130</bioguideId>
        <lastName>Vargas</lastName>
        <firstName>Juan</firstName>
        <identifiers>
          <gpoId />
          <bioguideId>V000130</bioguideId>
          <lisID>2112</lisID>
        </identifiers>
        <fullName>Rep. Vargas, Juan [D-CA-51]</fullName>
        <district>51</district>
        <byRequestType />
      </item>
    </sponsors>
    <summaries>
      <billSummaries>
        <item>
          <actionDate>2015-02-05</actionDate>
          <text><![CDATA[<p>Recognizes: the value of biomedicine, biotechnology, and life sciences; the challenges those industries face; and the ways those challenges can be addressed.</p>]]></text>
          <name>Introduced in House</name>
          <versionCode>00</versionCode>
          <actionDesc>Introduced in House</actionDesc>
          <updateDate>2015-02-05T05:00:00Z</updateDate>
          <lastSummaryUpdateDate>2015-02-09T23:25:09Z</lastSummaryUpdateDate>
        </item>
      </billSummaries>
    </summaries>
    <constitutionalAuthorityStatementText />
    <billType>HRES</billType>
    <title>Recognizing the importance of transformative breakthroughs in biomedicine, biotechnology, and life sciences in the diagnosis, management, curing, and treatment of illness and the existence of a "Valley of Death" in biotechnology and life sciences funding that stifles innovation and impedes translational medical research.</title>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <congress>114</congress>
    <latestAction>
      <text>Referred to the Subcommittee on Health.</text>
      <actionDate>2015-02-06</actionDate>
      <links />
    </latestAction>
    <cboCostEstimates />
    <originChamber>House</originChamber>
    <notes />
    <committees>
      <billCommittees>
        <item>
          <systemCode>hsif00</systemCode>
          <subcommittees>
            <item>
              <systemCode>hsif14</systemCode>
              <name>Health Subcommittee</name>
              <activities>
                <item>
                  <name>Referred to</name>
                  <date>2015-02-06T18:41:50Z</date>
                </item>
              </activities>
            </item>
          </subcommittees>
          <type>Standing</type>
          <chamber>House</chamber>
          <name>Energy and Commerce Committee</name>
          <activities>
            <item>
              <name>Referred to</name>
              <date>2015-02-05T14:06:35Z</date>
            </item>
          </activities>
        </item>
      </billCommittees>
    </committees>
    <calendarNumbers />
    <updateDate>2017-01-11T14:29:58Z</updateDate>
    <titles>
      <item>
        <chamberCode />
        <titleType>Official Title as Introduced</titleType>
        <chamberName />
        <title>Recognizing the importance of transformative breakthroughs in biomedicine, biotechnology, and life sciences in the diagnosis, management, curing, and treatment of illness and the existence of a "Valley of Death" in biotechnology and life sciences funding that stifles innovation and impedes translational medical research.</title>
        <parentTitleType />
      </item>
      <item>
        <chamberCode />
        <titleType>Display Title</titleType>
        <chamberName />
        <title>Recognizing the importance of transformative breakthroughs in biomedicine, biotechnology, and life sciences in the diagnosis, management, curing, and treatment of illness and the existence of a "Valley of Death" in biotechnology and life sciences funding that stifles innovation and impedes translational medical research.</title>
        <parentTitleType />
      </item>
    </titles>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

